1Connotation and development of drug regulatory science in the new situationLI Feng, HE Hui1921-19252Discussions on the range of toxic Chinese herbal medicines and other correlated issuesZHOU Yue-hua, LU Jin-cai1926-19403Analysis of monoclonal antibody drug registration in ChinaKAN Hong-jin, LIU Bo-ning, BAI Yu, LUO Jian-hui1941-19464Roles of the components of product formulation of monoclonal antibodies and the points to consider for drug evaluationQIU Xiao, LUO Jian-hui1947-19545Case introduction of PD-1 immune checkpoint inhibitors combined medication approved by FDAGAO Li-li, WANG Yu-zhu, YANG Jin-bo1955-19636Considerations on research and evaluation of virus safety for recombinant biological productsWEI Wei, XU Long-chang, BAI Yu, LUO Jian-hui1964-19687Analysis of repeated applications of approved biological productsLIU Zhi-lei, ZHANG Yan-yan, GAO En-ming1969-19748Discussion on quality control strategy and case study of mesenchymal stem cells products from regulatory perspectiveYU Shan-shan, WEI Kai-kun1975-19819Introduction to the ICH considerations on nonclinical studies of oncolytic virus products in conjugation with the practice of talimogene laherparepvecZHANG Min, GONG Xin-jiang, SHAO Xue, YAN Li-ping, YU Bing, YE Xuan, WANG Qing-li, WANG Hai-xue1982-198610Latest related requirements on starting materials for synthetic drug substancesWANG Hong-liang, WANG Huan1987-199011Evolution and progress of requirements for drug efficacy investigation of FDA and other regulatory agenciesLIU Bing-lin1991-199612Opportunities, challenges and countermeasures for the implementation of eCTDFAN Yi1997-200313Introduction and consideration of guideline on specifications of herbal medicines in European UnionYANG Ping, QU Jian-bo2004-200814Development dynamics of patented technology of PARP inhibitors in ChinaLI Wei, YAN Hua2009-201415Analysis of one example of information change for reference listed drugs in USAYANG Dong-sheng, MA Ling-yun, NAN Nan, NIU Jian-zhao, XU Ming-di2015-201816Pharmacokinetics and bioequivalence of compound sulfamethoxazole tablets in Chinese healthy volunteersFENG Shi-yin, CHEN Zhuo, CAI Lin-rui, YU Qin, SU Xu, ZOU Qin, GUO Wei-yi, WANG Jing, CHEN Guan-hua, JIANG Hong-mei, LU Ji-hong, SHI Hua-qin2019-202417The protection of curcumin salicyloyl monoester against acute radiation-induced lung injury in miceZHANG Jie-min, YE Sheng-nan, ZHANG Wei-jian, WANG Qiao-hong, XU Jian-hua2025-203118Study on chemical constituents of Tutcheria championi Nakai by UPLC-Q-ExactiveLU Shi-ying, WANG Hai-bo, YUAN Guang-wei, LI Yao-hua2032-203919Preparation and characterization of coixol-2-HP-β-CD clathrates lyophilized powderSHEN Xin-yu, XU Rong-rong, WANG Xing-chen, HUANG Gang, HU Rong2040-2048 